Clinical experience with a novel intracoronary perfusion catheter to treat no-reflow phenomenon in acute coronary syndromes

Journal of Interventional Cardiology

Volumn 23, Issue 2, 2010, Pages 109-113

  Maluenda, Gabriel ^a   Ben Dor, Itsik ^a   Delhaye, Cedric ^a   Gonzalez, Manuel A ^a   Collins, Sara D ^a   Torguson, Rebecca ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICARDIPINE; NITROPRUSSIDE SODIUM;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CATHETER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CORONARY ARTERY BLOOD FLOW; FEMALE; HUMAN; INTRACORONARY INFUSION; MALE; NO REFLOW PHENOMENON; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CATHETERIZATION; COHORT STUDIES; CORONARY CIRCULATION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NICARDIPINE; NITROPRUSSIDE; PERFUSION; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 77950572520     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00539.x     Document Type: Article

References (17)

1. Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: From the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv 2008 72 : 950 957.
2. Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol 2007 99 : 442 445. (Pubitemid 46223482)
3. Gibson CM, Cannon CP, Murphy SA, et al TIMI Study Group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002 105 : 1909 1913.
4. Bolognese L, Carrabba N, Parodi G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004 109 : 1121 1126. (Pubitemid 38332616)
5. Niccoli G, Burzotta F, Galiuto L, et al. Myocardial no-reflow in humans. J Am Coll Cardiol 2009 54 : 281 292.
6. US Food and Drug Administration device approval. http://www.accessdata. fda.gov/scripts/cdrh/devicesatfda/index.cfm?db=pmn&id=K061680 Accessed December 16, 2009.
7. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007 50 : 2173 2195. (Pubitemid 350123680)
8. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of CardiologyAmerican Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1993 22 : 2033 2054. (Pubitemid 23359668)
9. Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation 1987 72 : 817 829.
10. van't Hof AW, Liem A, Suryapranata H, et al Zwolle Myocardial Infarction Study Group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Circulation 1998 97 : 2302 2306. (Pubitemid 28280383)
11. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002 105 : 656 662.
12. Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-flow and no-reflow phenomenon. Chest 2002 122 : 1322 1332.
13. Ambrosio G, Weisman HF, Mannisi JA, et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989 80 : 1846 1861.
14. Tranum-Jensen J, Janse MJ, Fiolet WT, et al. Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine. Circ Res 1981 49 : 364 381.
15. Reffelmann T, Kloner RA. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol 2006 101 : 359 372.
16. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007 357 : 1121 1135.
17. Marzilli M, Gliozheni E, Marraccini P, et al. Primary coronary angioplasty in acute myocardial infarction: Clinical correlates of the 'no reflow' phenomenon. Int J Cardiol 1998 65 : S23 S28.